Insulin lispro
HALO-117-205
Phase 2 small_molecule completed
Quick answer
Insulin lispro for Diabetes Mellitus, Type 1 is a Phase 2 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- HALOZYME THERAPEUTICS, INC.
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed